Best Shares To Pick On The Australian Share Market
Shares to buy: Smartgroup Corporation Ltd (SIQ)
SmartgroupCorporation Limited engages in the provision of employee benefits and workforce optimization services. We covered SIQ in our April stock picks document. At that time it was trading around $6.50 and we had a price target on it of $7.50. It is now trading around $9. Whilst the stock has performed well, the company remains highly cash-generative with strong returns, and we can’t see any signs of earnings quality deteriorating. There is also evidence of management buying. So, the fundamental story remains strong and we’re confident SIQ can continue to deliver. After popping higher in August, the stock has spent the past few weeks consolidating around the $9 level. We’re comfortable buying towards this $9 level, with targets to $11.
Shares to buy: Boral Limited (BLD)
BLD is trading at a steep 25% discount to the All Industrials ex-financials on FY18 price/earnings estimates, which is significantly below the historical trading range. This is largely attributable to the proposed acquisition of Headwaters, reflecting the size of the transaction and concerns around coal-linked fly ash and regulatory approvals. In our opinion, investor concerns are overstated. The catalysts that could drive a re-rating include regulatory approvals, delivery on FY17 expectations and evidence of synergy execution. On the technical front, since November last year an uptrend has developed, characterised by a series of higher highs and higher lows. We like the recent compression in the shorter-term EMAs (red) and bounce from the longer-term EMAs (green). This suggests those active in the stock are willing to bid up dips and that longer-term momentum is becoming more bullish. We are targeting a move to $6.50.
Shares to buy: Downer EDI Limited (DOW)
Downer's 1H net profit of $78m beat most forecasts and FY17 net profit guidance was raised 7% - to $175M. The strong result suggests that the earnings recovery is well underway for Downer, and gaining momentum. The recent results release saw the stock pop sharply, up to $7.50. The stock has since retraced to close the gap, finding support in the $6.60 region. Yesterday's action saw a buy signal off this support region and that's our opportunity to consider longs. Traders can be buyers around current levels, with targets to $7.50.
Shares to buy: Fortescue Metals Group (FMG)
FMG recently confirmed that it is on track to hit the top end of its iron ore export guidance, and possibly exceed it, whilst at the same time continue to cut costs. The company also took its unit costs below $US13 per tonne for the first time in the December quarter, with an average "C1" cost of $US12.54 per wet metric tonne. Fortescue has now lowered its cost for a 12th consecutive quarter. The company managed to pay down another $US1 billion of debt in the past quarter and said it held $US1.2 billion in cash at the end of December, while net debt stood at $US4 billion. After reporting another strong quarter of shipments and cost cuts, chief executive Nev Power said shareholders could be in line for better returns. "We need to continue diverting most of our cash flow to repaying debt. But we will progressively look to increase returns to shareholders," he told reporters. The company declared a 12 cents per share final dividend in August, exceeding analyst expectations. It will declare its next interim dividend on February 22. These are obviously all positives for a company that continues to deliver on its guidance, cut costs and pay down debt, and we believe that market will continue to reward FMG by bidding up its shares. Technically, the stock is in a fairly well defined uptrend, where momentum is strong but not currently overdone. Targets are towards $8.
Share to buy: Nanosonics (NAN)
December quarter sales were up 41% on the prior quarter, as North American direct sales gained momentum.
The company's move into the US market seems to be paying off, with gross margins improving significantly.
The next driver of share price could be publication of decontamination guidelines in the UK and Scotland favourable to Nanosonic products.
Technically, the stock remains strong and has broken out to fresh all-time highs recently on rising volumes.
Share to buy – Whitehaven Coal (WHC)
Until recently, we've viewed a lack of market confidence as mis-pricing WHC.
Over the journey, the company has maintained an earnings margin average of $13/t but it appears the market has been factoring in the future coal price and giving management little benefit for being able to sustain its margins, despite its track record.
The risk lies with the thermal coal price outlook and whether China continues to retreat from the trade.
Today the company announced record high ROM coal production of 5.7Mt for the March quarter, up 21% compared with the previous corresponding period and 44% YTD.
The company also recorded its highest quarterly saleable coal production of 5.3 Mt for March, up 28% compared to a year earlier, and 48% YTD.
Whitehaven Coal says that it is on track to meet FY2016 guidance for saleable coal to be in the range of 19.5 Mt to 20.1 Mt.
The miner says that costs guidance for the full year FY2016 is now expected to be $57/t.
We think momentum can now build in the stock and are prepared to be buyers..
Share to buy – Ramsay Healthcare (RHC)
- Market cap: $12.01 Billion
- Recent share price: $59.9
- Cash/debt: $315.86 million/$3.17B
- Trailing P/E: 32.64
Ramsay Healthcare is the largest private hospital operator in Australia and one of the top five hospital companies in the world. It has a presence in the UK, France, Indonesia and Malaysia. In Nov 2015, they inked a joint venture agreement with one of China's leading medical universities to build a number of new private hospitals in China's Pearl River Delta thus expanding its reach further.
RHC has a strong competitive advantage, which it has leveraged to grow its business. Key features include;
- Guaranteed demand given the growing ageing populations on a global scale
- Pricing power over its customers, insurers and governments, which often have no alternative but to use Ramsay’s services.
- Buying and building hospitals is very expensive and this is a major deterrent to other companies looking to enter the market.
- Ramsay has also proven to be very astute at building new beds at just the right pace to grow earnings without increasing supply beyond demand.
- Ramsay delivered solid growth in FY15 with revenues, core earnings per share and full year dividends increasing by 49.8%, 20% and 18.8% respectively.
- Management has provided guidance of 12-14% earnings per share growth in FY16 barring any unforeseen circumstances.
Share to buy – NIB Holdings Limited (NHF)
- Market cap: $1.48 Billion
- Recent share price: $3.38
- Cash/debt: $58.81 million/$63.89Million
- Trailing P/E: 19.54
NIB health funds is one of Australia’s largest health insurers, providing health and medical cover to more than 1.1 million Australian and New Zealand residents
Private Health insurers are a segment of the market worth watching over the coming 12 months.
Both Medibank Private and NIB have become increasingly vocal about the need to improve efficiencies in the healthcare system and to put a lid on the spiralling cost of care.
With federal reviews into private health insurance and the Medicare Benefits Schedule, among other parts of the health system, there could be significant changes in fortune for the insurers who pay medical bills.
Throughout 2015, NIB shares have been volatile after rising to nearly $3.90 in March before falling to a low of $3 in October.
However, consistent profit and dividend growth has been a regular feature from NIB in recent years helping the company’s share price lift 10% for FY 15/16.
Share to buy – BHP Billiton (BHP)
The big question on every investor’s lips right now is, ‘Should I buy BHP?’
The Big Australian has fallen sharply in the last 12 months, having given up half of its value.
The rout has come about due to slowing growth out of China and a subdued outlook for global economic growth.
The Samarco mine disaster in Brazil has also weighed heavily, with BHP and partner Vale expected to be footing a multi-billion dollar bill for the tailings dam failure.
These factors, coupled with massive oversupply in key iron ore and oil markets, have driven the share price south.
But commodity slumps don’t last forever; booms turn to busts and back to booms in due course.
And over the cycle, BHP has remained and will remain one of, it not the world’s best diversified mining companies, with an enviable portfolio of world-class assets.
If you have a long-term investment horizon and are willing to put up with some volatility, now could be an ideal time to revisit BHP given the depressed share price.
Share to sell – Graincorp (GNC)
GNC’s FY15 result was in line with the company’s guidance. We suspect that FY16 will be another below-average year for cropping and the winter harvest is likely to be downgraded over coming weeks. With the effects of the El Nino weather phenomenon also likely to weigh – through lower crop yields and less revenue from GNC’s grain handling business – as well as the stock being on the verge of breaking down technically, we feel shorts are an appropriate course of action. We wouldn’t be surprised to see the stock move towards the $6.50 region over the next 6-12 months.
VIEW SHARE market recommendations BY CATEGORY
Nov 2014 - Nov 2016
Our short-term focused Trading Report returned 30.03%, outperforming the ASX/200 Accumulation Index by 23.58%*
DISCLAIMER: *Performance is derived from recommendations provided by Australian Stock Report’s Trading Report, opened on or after date of acquisition in Nov 2014 *Return figures are gross returns and do not take into account fees or brokerage costs. *Returns are calculated based on a $50,000 hypothetical portfolio, risking 2% of the overall portfolio balance ($1,000) as a starting point for each trade. *Due to slippage and gapping, losses can sometimes exceed $1,000 on an individual trade. *Opening and closing prices for trades (and therefore the prices used for determining aggregate profit/loss) will be those published on the Australian Stock Report website and will be determined by the price at which they could realistically be executed in the market at the time the recommendation is published. *ASX 200 Accumulation Index Return is calculated based upon the price of the index at the start of the session on the day the first ASX 200 trade was placed, i.e. 24.11.2015
Start your 7 day FREE trial and get
access to our premium reports!
We’re here to help
Need to speak to someone about companies or investing?
Our knowledgeable team is on hand to assist